These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Outcome of thrombolytic therapy in relation to hospital size and invasive cardiac services. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Barbash GI, White HD, Modan M, Diaz R, Hampton JR, Heikkila J, Kristinsson A, Moulopoulos S, Paolasso EA, Van der Werf T. Arch Intern Med; 1994 Oct 10; 154(19):2237-42. PubMed ID: 7944845 [Abstract] [Full Text] [Related]
4. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group. Maggioni AP, Franzosi MG, Santoro E, White H, Van de Werf F, Tognoni G. N Engl J Med; 1992 Jul 02; 327(1):1-6. PubMed ID: 1598096 [Abstract] [Full Text] [Related]
6. Six-month survival in 20,891 patients with acute myocardial infarction randomized between alteplase and streptokinase with or without heparin. GISSI-2 and International Study Group. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto. Eur Heart J; 1992 Dec 02; 13(12):1692-7. PubMed ID: 1289101 [Abstract] [Full Text] [Related]
7. [Thrombolytic therapy for acute myocardial infarction: circadian sensitivity]. Kharash LM, Goldkhammer EI. Ter Arkh; 1999 Dec 02; 71(12):13-7. PubMed ID: 10647192 [Abstract] [Full Text] [Related]
8. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery. Dwivedi SK, Saran RK, Narain VS, Bansal S, Gupta R, Puri VK. Indian Heart J; 2000 Dec 02; 52(1):40-4. PubMed ID: 10820932 [Abstract] [Full Text] [Related]
9. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar. Hadi HA, Al Suwaidi J, Bener A, Khinji A, Al Binali HA. Int J Cardiol; 2005 Jul 10; 102(2):249-54. PubMed ID: 15982492 [Abstract] [Full Text] [Related]
12. [Risk factors and physical activity levels at the onset of acute myocardial infarction in young men]. Miyamoto S, Goto Y, Sumida H, Yasuda S, Matsumoto T, Morii I, Daikoku S, Itoh A, Miyazaki S, Nonogi H. J Cardiol; 2000 Aug 10; 36(2):75-83. PubMed ID: 10955251 [Abstract] [Full Text] [Related]
17. Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2). Maggioni AP, Maseri A, Fresco C, Franzosi MG, Mauri F, Santoro E, Tognoni G. N Engl J Med; 1993 Nov 11; 329(20):1442-8. PubMed ID: 8413454 [Abstract] [Full Text] [Related]
18. Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I. Kaul P, Armstrong PW, Chang WC, Naylor CD, Granger CB, Lee KL, Peterson ED, Califf RM, Topol EJ, Mark DB. Circulation; 2004 Sep 28; 110(13):1754-60. PubMed ID: 15381645 [Abstract] [Full Text] [Related]
19. [Acute myocardial infarction in young Japanese women]. Toyofuku M, Goto Y, Matsumoto T, Miyao Y, Morii I, Daikoku S, Itoh A, Miyazaki S, Nonogi H. J Cardiol; 1996 Dec 28; 28(6):313-9. PubMed ID: 8986854 [Abstract] [Full Text] [Related]
20. Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators. Stone GW, Grines CL, Browne KF, Marco J, Rothbaum D, O'Keefe JH, Hartzler GO, Overlie P, Donohue B, Chelliah N, Vlietstra R, Puchrowicz-Ochocki S, O'Neill WW. Cathet Cardiovasc Diagn; 1996 Dec 28; 39(4):333-9. PubMed ID: 8958418 [Abstract] [Full Text] [Related] Page: [Next] [New Search]